New dosing strategy aims to get MRSA treatment right faster in kids
NCT ID NCT02694458
First seen Jan 08, 2026 · Last updated Jun 15, 2026 · Updated 31 times
Summary
This study tested a new method to adjust vancomycin doses in 100 children with MRSA infections. The goal was to reach the right drug level in the blood more quickly and safely than with the usual approach. The new method uses a computer model (Bayesian approach) to personalize dosing.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METHICILLIN-RESISTANT STAPHYLOCOCCAL INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hôpital Necker-Enfants Malades
Paris, Paris, 75015, France
Conditions
Explore the condition pages connected to this study.